跳至主要内容
临床试验/NL-OMON38088
NL-OMON38088已完成4 期

DIAbetes-PREvention Trial - DiaPreT

Isala Klinieken0 个研究点目标入组 78 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
78

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Inclusion criteria ;• • Patients admitted with coronairy artery disease (PCI or CABG in stable CAD, or post STEMI and post non-STEMI) (inclusion within 2 month after admission) ;• Age >= 18 years ;• Elevated HbA1c levels (HbA1c > 5.8% or > 40 mmol/mol) on admission ;• Access to a computer with internet connection;• Written informed consent

排除标准

  • Exclusion criteria ;• Known diabetics, with or without anti-diabetic medication ;• Contra-indications for Metformine use as stated in the medication registration;• Life Expectancy <1 yr ;• Physical limitations/restrictions for participation in exercise programme or exercise testing ;• Fasting plasma glucose >= 7.0 mmol/l or HbA1c >= 53

研究者

发起方
Isala Klinieken

相似试验